Stormy Chamberlain is associate professor of genetics and genome sciences and associate director of the Graduate Program in Genetics and Developmental Biology at the University of Connecticut School of Medicine.
Stormy Chamberlain
Associate professor
University of Connecticut
From this contributor
Angelman syndrome’s silent gene points way forward for autism therapies
Advances in research and help from families have brought scientists to the brink of an effective therapy for Angelman syndrome.
Angelman syndrome’s silent gene points way forward for autism therapies
By
Stormy Chamberlain
21 October 2019 | 4 min read
For accurate results in autism, genetic databases need diversity
We must diversify databases of reference DNA to improve our ability to interpret the consequences of genetic variation.
For accurate results in autism, genetic databases need diversity
By
Stormy Chamberlain, Louisa Kalsner
10 April 2018 | 5 min read
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
By
Amber Dance
18 September 2026 | 9 min read
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
By
Brendan Borrell
17 September 2026 | 4 min read
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
By
Brady Huggett
17 September 2026 | 2 min read